Download Docs
Export

REXULTI

79114561 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed March 26, 2012
Serial No. 79114561
Registered Feb. 12, 2013
Registration No. 4,287,396
Interlocutory Attorney GEORGE POLOGEORGIS
Class Pharmaceutical preparation and substances for the [ prevention and ] treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the [ prevention and ] treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the [ prevention and ] treatment of [ Alzheimer's disease, ] depression, psychosis, [ anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, ] and schizophrenia [, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes ]; 006; 018; 044; 046; 051; 052
REXULTI
Status A Section 71 declaration has been accepted.
Opposition 91214311
H. Lundbeck A/S v. Teva Pharmaceuticals USA, Inc.
  • Teva Pharmaceuticals USA, Inc.;
  • H. Lundbeck A/S;
Last Updated: 3 months, 3 weeks ago
Filing Date # Docket Text